CORE--CLINICAL PHENOTYPES AND RESOURCES

$347,079P01FY2000HLNIH

Southwest Foundation For Biomedical Res, San Antonio TX

Investigators

Linked publications & trials

Paper 38790197 Paper 38495670 Paper 38474333 Paper 37425772 Paper 36564505 Paper 36220816 Paper 35902682 Paper 35734277 Paper 35530816 Paper 35183128 Paper 34645953 Paper 34553764 Paper 33887960 Paper 33057385 Paper 32839606 Paper 31860654 Paper 31544985 Paper 31227640 Paper 30188589 Paper 29265408 Paper 29239496 Paper 28525987 Paper 28377602 Paper 27896278 Paper 27375745 Paper 27117576 Paper 27044508 Paper 27039371 Paper 26798409 Paper 26101197 Paper 25885044 Paper 25758998 Paper 25585699 Paper 25405847 Paper 25363705 Paper 24962563 Paper 24915116 Paper 24913450 Paper 24627127 Paper 24390345 Paper 24379826 Paper 24243780 Paper 24086336 Paper 24081229 Paper 24058506 Paper 24045843 Paper 23970733 Paper 23929697 Paper 23874812 Paper 23868910 Paper 23798346 Paper 23796311 Paper 23707588 Paper 23689979 Paper 23572186 Paper 23536864 Paper 23494580 Paper 23487405 Paper 23420437 Paper 23419715 Paper 23326239 Paper 23160725 Paper 23074152 Paper 23010875 Paper 22917222 Paper 22909773 Paper 22871458 Paper 22797999 Paper 22692763 Paper 22577559 Paper 22558002 Paper 22373155 Paper 22373104 Paper 22155241 Paper 22155176 Paper 22018212 Paper 22011848 Paper 21996708 Paper 21978175 Paper 21483430 Paper 21465549 Paper 21343950 Paper 21135356 Paper 20724716 Paper 20489166 Paper 20450993 Paper 20439422 Paper 20045148 Paper 20009011 Paper 19862556 Paper 19763161 Paper 19546579 Paper 19468830 Paper 19067020 Paper 19056704 Paper 19001525 Paper 18985387 Paper 18971955 Paper 18668207 Paper 18478967

Abstract

The overall objective of the Clinical Phenotypes and Resources Core is to serve all projects by maintaining the blood sample collection, by providing clinical phenotype data from lipoprotein and fibrinolysis assays, and by providing statistical analyses of assays done in this core and in Core A. The lipoprotein and fibrinolysis data will be analyzed in Projects 1, 2, and 3 for evidence of genes that affect plasma levels (either mass or function, depending on the measure). White blood cells will be provided to Project 2 for DNA extraction. Blood samples will be processed and catalogued, and the components stored at -80 degreeC. An up- to-date inventory of the remaining volume of each sample will be maintained. Plasma and serum aliquots will be delivered to Program Project investigators and technical staff as needed. Lipoprotein phenotypes to determined on each plasma sample are TG, TC, and HDL-C by clinical chemical techniques; LDL size distribution by nondenaturing gradient gel electrophoresis; and Lp(a) and isoform-specific Lp(a) concentrations. Fibrinolytic phenotypes include plasma concentrations of fibrinogen, tissue type plasminogen activator (t-PA), and fibrin fragment D-dimer; and plasma activity of plasminogen. Quantitative data from blind duplicates will be monitored and evaluated. The investigators in this core will collaborate with investigators in the projects in analyzing data and preparing manuscripts.

View original record on NIH RePORTER →